公司資料
Intelligent Bio Solutions 股價、新聞與催化劑
- 股票代碼:
- INBS
- 交易所:
- NASDAQ
- 產業:
- MedTech
- 所在地:
- United States
股票表現
1.66 USD (-0.60%)
收盤價
最後更新: 2026年10月1日
6.08M USD
市值
股價為何變動
截至 2026年10月1日，INBS 下跌 0.60%，收於 $1.66。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
Fingerprint Drug Screening Company
Intelligent Bio Solutions develops rapid, non-invasive drug-testing systems that analyze fingerprint sweat. Its platform is used in workplace and safety-sensitive environments outside the United States.
Intelligent Fingerprinting System
The system combines a disposable collection cartridge with a portable reader and software. A fingerprint sweat sample is collected in seconds, and the reader can provide screening results in under ten minutes.
Drug Detection Menu
Commercial cartridges screen for commonly abused substances including opiates, cocaine, methamphetamine, and cannabis. The company is pursuing an initial U.S. clearance for codeine detection.
Reader-and-Cartridge Model
INBS places or sells readers and generates recurring revenue from single-use cartridges. Growth in the installed base increases the opportunity for repeat consumable sales as customers conduct routine testing.
Workplace and International Markets
Customers include logistics, construction, manufacturing, drug-treatment, and other organizations where impairment creates safety risks. The business is established in the United Kingdom and other markets while preparing for U.S. entry.
未來催化劑
- FDA 510(k) submission for the Intelligent Fingerprinting Drug Screening System in the second half of 2026.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。